Cyteir Therapeutics

Darryl Patrick, PhD, DVM

Acting Head of Preclinical Research and Development

Dr. Patrick has over 25 years of outstanding success in pharmaceutical research and development.  He     has expertise in preclinical safety assessment, toxicology, veterinary anatomy, veterinary internal medicine and early drug development.   He had a 20-year career at Merck culminating as Vice President for Non-Clinical Development.  Dr. Patrick then moved to Vertex Pharmaceuticals, becoming the Vice President for Exploratory Development. For his excellence and success in preclinical R&D Dr. Patrick has received numerous awards, including the prestigious Prix Galien in 2000.  He started his career in veterinary sciences with the US Air Force becoming Chief of Diagnostic and Comparative Medicine for the Uniformed Services, University of Health Sciences. He is trained in veterinary anatomy, laboratory animal pathology and veterinary internal medicine with expereince in toxicology, preclinical safety and early drug development. He holds a DVM from Michigan State University and a PhD from Iowa State University.